TIAA CREF Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $4M | Sell |
115,135
-3,364
| -3% | -$117K | ﹤0.01% | 1589 |
|
|
2018
Q4 | $2.31M | Sell |
118,499
-5,872
| -5% | -$115K | ﹤0.01% | 1868 |
|
|
2018
Q3 | $3.31M | Sell |
124,371
-51,978
| -29% | -$1.38M | ﹤0.01% | 1857 |
|
|
2018
Q2 | $6.66M | Sell |
176,349
-25,804
| -13% | -$975K | ﹤0.01% | 1406 |
|
|
2018
Q1 | $6.6M | Sell |
202,153
-19,384
| -9% | -$633K | ﹤0.01% | 1383 |
|
|
2017
Q4 | $10.8M | Buy |
221,537
+5,061
| +2% | +$246K | 0.01% | 1095 |
|
|
2017
Q3 | $11.7M | Buy |
216,476
+2,284
| +1% | +$123K | 0.01% | 1050 |
|
|
2017
Q2 | $12M | Sell |
214,192
-9,732
| -4% | -$547K | 0.01% | 1026 |
|
|
2017
Q1 | $8.78M | Buy |
223,924
+8,673
| +4% | +$340K | 0.01% | 1207 |
|
|
2016
Q4 | $4.83M | Sell |
215,251
-23,696
| -10% | -$532K | ﹤0.01% | 1629 |
|
|
2016
Q3 | $5.43K | Buy |
238,947
+5,370
| +2% | +$122 | ﹤0.01% | 1554 |
|
|
2016
Q2 | $5.51M | Buy |
233,577
+16,445
| +8% | +$388K | ﹤0.01% | 1472 |
|
|
2016
Q1 | $4.43M | Buy |
217,132
+23,190
| +12% | +$473K | ﹤0.01% | 1583 |
|
|
2015
Q4 | $9.98M | Buy |
193,942
+5,859
| +3% | +$301K | 0.01% | 1071 |
|
|
2015
Q3 | $8.02M | Sell |
188,083
-8,483
| -4% | -$362K | 0.01% | 1186 |
|
|
2015
Q2 | $8.95M | Sell |
196,566
-6,396
| -3% | -$291K | 0.01% | 1232 |
|
|
2015
Q1 | $7.7M | Buy |
202,962
+2,990
| +1% | +$113K | 0.01% | 1330 |
|
|
2014
Q4 | $5.66M | Buy |
199,972
+10,057
| +5% | +$285K | ﹤0.01% | 1544 |
|
|
2014
Q3 | $4.8M | Buy |
189,915
+4,786
| +3% | +$121K | ﹤0.01% | 1643 |
|
|
2014
Q2 | $5.4M | Buy |
185,129
+100,100
| +118% | +$2.92M | ﹤0.01% | 1644 |
|
|
2014
Q1 | $2.2M | Buy |
85,029
+10,169
| +14% | +$263K | ﹤0.01% | 2186 |
|
|
2013
Q4 | $1.93M | Buy |
74,860
+30,560
| +69% | +$787K | ﹤0.01% | 2276 |
|
|
2013
Q3 | $1.19M | Buy |
44,300
+5,348
| +14% | +$143K | ﹤0.01% | 2519 |
|
|
2013
Q2 | $957K | Buy |
+38,952
| New | +$957K | ﹤0.01% | 2609 |
|